Profile
Barry Gumbiner formerly worked at Merck & Co., Inc., as Director-Clinical Research & Metabolism in 2006, Metabasis Therapeutics, Inc., as Chief Medical Officer & VP-Clinical Development in 2009, and Indiana University, as Associate Professor.
Dr. Gumbiner received his undergraduate degree from the University of Southern California and undergraduate degree from the University of California, Los Angeles.
Former positions of Barry Gumbiner
| Companies | Position | End |
|---|---|---|
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | 13/10/2009 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 31/08/2006 |
| Indiana University | Corporate Officer/Principal | - |
Training of Barry Gumbiner
| University of California, Los Angeles | Undergraduate Degree |
| University of Southern California | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Private companies | 1 |
|---|---|
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Barry Gumbiner
